B. R. Winterhalter

495 total citations
15 papers, 396 citations indexed

About

B. R. Winterhalter is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, B. R. Winterhalter has authored 15 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in B. R. Winterhalter's work include Cancer Research and Treatments (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Biochemical and Molecular Research (2 papers). B. R. Winterhalter is often cited by papers focused on Cancer Research and Treatments (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Biochemical and Molecular Research (2 papers). B. R. Winterhalter collaborates with scholars based in Germany, United States and Netherlands. B. R. Winterhalter's co-authors include Dietmar Berger, Heinz‐Herbert Fiebig, Heiner Fiebig, Heinz H. Fiebig, H. Grunicke, Johann Hofmann, H. Henß, W. A. Dengler, J A Double and Willem Verboom and has published in prestigious journals such as Journal of Medicinal Chemistry, Annals of Oncology and International Journal of Cancer.

In The Last Decade

B. R. Winterhalter

15 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. R. Winterhalter Germany	10	168	141	121	57	41	15	396
Hiroshi Shirota Japan	11	141 0.8×	103 0.7×	153 1.3×	49 0.9×	29 0.7×	39	513
Hirofumi Kon Japan	6	205 1.2×	119 0.8×	88 0.7×	59 1.0×	21 0.5×	27	541
Paulo Eduardo Pizão Netherlands	4	224 1.3×	188 1.3×	114 0.9×	41 0.7×	13 0.3×	5	448
Alain Pierré France	8	270 1.6×	135 1.0×	107 0.9×	78 1.4×	18 0.4×	15	406
Helen M. Eliot United States	8	212 1.3×	193 1.4×	60 0.5×	32 0.6×	27 0.7×	9	409
R.E.C. Henrar Netherlands	14	244 1.5×	125 0.9×	116 1.0×	82 1.4×	14 0.3×	23	448
Xiaoguo H. Zhan United States	9	336 2.0×	133 0.9×	74 0.6×	95 1.7×	24 0.6×	9	715
Athanasios Papageorgiou Greece	10	157 0.9×	143 1.0×	135 1.1×	41 0.7×	14 0.3×	22	449
Sotiris S. Nikolaropoulos Greece	16	336 2.0×	105 0.7×	328 2.7×	67 1.2×	25 0.6×	49	637
Yuichi Kakudo Japan	10	286 1.7×	145 1.0×	68 0.6×	48 0.8×	26 0.6×	15	505

Countries citing papers authored by B. R. Winterhalter

Since Specialization

Citations

This map shows the geographic impact of B. R. Winterhalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. R. Winterhalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. R. Winterhalter more than expected).

Fields of papers citing papers by B. R. Winterhalter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. R. Winterhalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. R. Winterhalter. The network helps show where B. R. Winterhalter may publish in the future.

Co-authorship network of co-authors of B. R. Winterhalter

This figure shows the co-authorship network connecting the top 25 collaborators of B. R. Winterhalter. A scholar is included among the top collaborators of B. R. Winterhalter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. R. Winterhalter. B. R. Winterhalter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vergin, H, G. Mahr, B. R. Winterhalter, & R. Wigand. (2011). Relative Bioavailability and Bioequivalence Study of Theophylline Sustained Release Formulations. Arzneimittelforschung. 53(9). 635–639. 3 indexed citations

Vergin, H, Urs Fisch, G. Mahr, & B. R. Winterhalter. (2002). Analysis of formulation and food effect on the absorption of metoclopramide. International Journal of Clinical Pharmacology and Therapeutics. 40(4). 169–174. 3 indexed citations

Hartmann, R., Christoph Bührer, B. R. Winterhalter, et al.. (1997). Acute toxicity and effectiveness of idarubicin in childhood acute lymphoblastic leukemia. European Journal Of Haematology. 58(5). 326–332. 5 indexed citations

Engert, Andreas, R. Schnell, Marcel Reiser, et al.. (1997). A Phase-II Study with Idarubicin, Ifosfamide and VP-16 (IIVP-16) in Patients with Refractory or Relapsed Aggressive and High Grade non-Hodgkin's Lymphoma. Leukemia & lymphoma. 24(5-6). 513–522. 13 indexed citations

Schilling, T., Heiner Fiebig, B. R. Winterhalter, et al.. (1996). Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients. Investigational New Drugs. 14(4). 371–378. 23 indexed citations

Fiebig, Heinz‐Herbert, et al.. (1992). Combined In Vitro/In Vivo Test Procedure with Human Tumor Xenografts for New Drug Development. PubMed. 165(7). 321–351. 45 indexed citations

Berger, Dietmar, et al.. (1992). Preclinical activity off hepsulfam and busulfan in solid human tumor xenografts and human bone marrow. Anti-Cancer Drugs. 3(5). 531–540. 5 indexed citations

Hofmann, Johann, Heiner Fiebig, B. R. Winterhalter, Dietmar Berger, & H. Grunicke. (1990). Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetin. International Journal of Cancer. 45(3). 536–539. 72 indexed citations

Fiebig, Heinz‐Herbert, Dietmar Berger, B. R. Winterhalter, & Jacqueline Plowman. (1990). In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts. Cancer Treatment Reviews. 17(2-3). 109–117. 32 indexed citations

10.

Berger, Dietmar, et al.. (1990). Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts. European Journal of Cancer and Clinical Oncology. 26(8). 901–905. 46 indexed citations

11.

Berger, Dietmar, et al.. (1990). Preclinical phase II study of ifosfamide in human tumour xenografts in vivo. Cancer Chemotherapy and Pharmacology. 26(S1). S7–S11. 28 indexed citations

12.

Berger, Dietmar, H. Henß, B. R. Winterhalter, & Heinz‐Herbert Fiebig. (1990). The clonogenic assay with human tumor xenografts: Evaluation, predictive value and application for drug screening. Annals of Oncology. 1(5). 333–341. 26 indexed citations

13.

Verboom, Willem, David N. Reinhoudt, P. Lelieveld, et al.. (1989). Synthesis, mechanism of action, and biological evaluation of mitosenes. Journal of Medicinal Chemistry. 32(7). 1612–1620. 81 indexed citations

14.

Fiebig, Heinz H., et al.. (1989). CGP 6809 ? A new nitrosoureido-sugar derivative with activity in human tumor xenografts. Cancer Chemotherapy and Pharmacology. 23(6). 337–340. 5 indexed citations

15.

Leder, Gerhard, et al.. (1987). In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET‐18‐OCH₃ and thioether lipid BM 41.440. Lipids. 22(11). 958–961. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact